Ultimately the “opioid crisis” is not about opioids, it is about addiction and mental health and societal despair. In fact, the majority of drug overdose…
OPINION: By Roger Crystal, M.D. The national opioid epidemic poses multifaceted challenges for prescribers. One of the central questions involves the sizable population of patients…
By Staff In an email sent to their Pain Ambassadors-Advocates on Wed, March 1st, U.S. Pain Foundation asked their members to take action against proposed…
By Ed Coghlan The U.S. Food and Drug Administration (FDA) is launching 2016 Naloxone App Competition. According to the Agency, the competition is a public…
Today, the FDA announced it is requiring a class-wide change to drug labeling and patient information to address the serious risks associated with the combined…